Panacos Pharmaceuticals (Panacos Pharmaceuticals) Net Income From Continuing Operations : $-35.76 Mil (TTM As of Sep. 2008)

View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Panacos Pharmaceuticals's net income from continuing operations for the three months ended in Sep. 2008 was $-8.15 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2008 was $-35.76 Mil.

Panacos Pharmaceuticals Net Income From Continuing Operations Historical Data

The historical data trend for Panacos Pharmaceuticals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Net Income From Continuing Operations Chart

Panacos Pharmaceuticals Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Net Income From Continuing Operations

Get a 7-Day Free Trial

-4.51

-12.04

-59.08

-38.11

-37.46

Panacos Pharmaceuticals Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
Net Income From Continuing Operations	Get a 7-Day Free Trial															-7.91	-9.35	-8.51	-9.74	-8.15

Panacos Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.76 Mil.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

134 Coolidge Avenue, Watertown, MA, USA, 02472

Website

http://www.panacos.com

Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines